Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read More
ADC Therapeutics SA
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Shares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the
Read More
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
CAR-T immunotherapies and antibody drug conjugates will highlight the American Society of Clinical Oncology's cancer research conference that starts Thursday.
Read More